DiaSorin S.p.A. (OTCMKTS:DSRLF - Get Free Report) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 162,400 shares, a decline of 25.8% from the February 28th total of 218,900 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days. Approximately 0.3% of the shares of the stock are sold short.
DiaSorin Price Performance
DiaSorin stock remained flat at $109.60 during midday trading on Thursday. The firm has a 50 day moving average of $105.84 and a 200-day moving average of $104.96. DiaSorin has a 12 month low of $100.26 and a 12 month high of $109.60.
About DiaSorin
(
Get Free Report)
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Further Reading
Before you consider DiaSorin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DiaSorin wasn't on the list.
While DiaSorin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
